NKTX
Price
$1.67
Change
-$0.01 (-0.60%)
Updated
Jun 30, 01:10 PM (EDT)
Capitalization
117.79M
38 days until earnings call
SLNO
Price
$83.98
Change
+$0.74 (+0.89%)
Updated
Jun 30, 03:45 PM (EDT)
Capitalization
4.2B
37 days until earnings call
Interact to see
Advertisement

NKTX vs SLNO

Header iconNKTX vs SLNO Comparison
Open Charts NKTX vs SLNOBanner chart's image
Nkarta
Price$1.67
Change-$0.01 (-0.60%)
Volume$300
Capitalization117.79M
Soleno Therapeutics
Price$83.98
Change+$0.74 (+0.89%)
Volume$800
Capitalization4.2B
NKTX vs SLNO Comparison Chart in %
Loading...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NKTX vs. SLNO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTX is a Buy and SLNO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (NKTX: $1.67 vs. SLNO: $83.25)
Brand notoriety: NKTX and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTX: 130% vs. SLNO: 371%
Market capitalization -- NKTX: $117.79M vs. SLNO: $4.2B
NKTX [@Biotechnology] is valued at $117.79M. SLNO’s [@Biotechnology] market capitalization is $4.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTX’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • NKTX’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNO is a better buy in the long-term than NKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTX’s TA Score shows that 2 TA indicator(s) are bullish while SLNO’s TA Score has 4 bullish TA indicator(s).

  • NKTX’s TA Score: 2 bullish, 6 bearish.
  • SLNO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLNO is a better buy in the short-term than NKTX.

Price Growth

NKTX (@Biotechnology) experienced а -5.37% price change this week, while SLNO (@Biotechnology) price change was +4.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.95%, and the average quarterly price growth was +6.81%.

Reported Earning Dates

NKTX is expected to report earnings on Aug 07, 2025.

SLNO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($4.2B) has a higher market cap than NKTX($118M). SLNO YTD gains are higher at: 85.206 vs. NKTX (-32.731). NKTX has higher annual earnings (EBITDA): -122.8M vs. SLNO (-194.63M). SLNO has more cash in the bank: 290M vs. NKTX (266M). SLNO has less debt than NKTX: SLNO (52.8M) vs NKTX (78.9M). NKTX (0) and SLNO (0) have equivalent revenues.
NKTXSLNONKTX / SLNO
Capitalization118M4.2B3%
EBITDA-122.8M-194.63M63%
Gain YTD-32.73185.206-38%
P/E RatioN/AN/A-
Revenue00-
Total Cash266M290M92%
Total Debt78.9M52.8M149%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NKTXSLNO
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SILDF5.09N/A
N/A
Sintokogio Ltd.
NCSYF167.10N/A
N/A
NICE Ltd.
TOIPF1.00N/A
N/A
Thai Oil Public Co., Ltd.
DVHGF0.18N/A
N/A
Devonian Health Group Inc.
APHP0.14-0.05
-27.88%
American Picture House Corporation

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with CRBU. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-3.18%
CRBU - NKTX
51%
Loosely correlated
-6.67%
BEAM - NKTX
49%
Loosely correlated
-1.98%
FATE - NKTX
48%
Loosely correlated
-5.45%
IPSC - NKTX
47%
Loosely correlated
-5.74%
TERN - NKTX
46%
Loosely correlated
-4.25%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with SYRE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-0.92%
SYRE - SLNO
43%
Loosely correlated
-4.99%
NKTX - SLNO
43%
Loosely correlated
-3.18%
IMVT - SLNO
39%
Loosely correlated
-1.77%
CRNX - SLNO
39%
Loosely correlated
-0.10%
IDYA - SLNO
39%
Loosely correlated
-4.13%
More